The inhibition of AKT by shikonin activated the forkhead box (FOX)O3a/early growth response protein (EGR)1 signaling cascade and enhanced the expression of the target gene Bim, leading to apoptosis in lung cancer cells (Jeung et al., 2016). The gene discussed is AKT1; the disease is lung carcinoma.